Alvotech
ALVO
5.85
-0.29
-4.72%
Alvotech
US · ALVO
#2709 by market cap
Listed 2020
5.85
-0.29
-4.72%
Live - 5344 symbols - heartbeat 239s ago
· 2026-10-08 09:12
Pre-market
5.90
+0.85%
After-hours
5.83
-0.43%
Overnight
6.00
+2.56%
- Market cap
- 2.09B
- P/E (TTM)i
- -9.59
- P/Bi
- -10.34
- EPSi
- 0.10
- Div yieldi
- 0.00%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on ALVO?
Anonymous reader poll. Unscientific, not investment advice.
About Alvotech
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
- Founded
- 2021
- CEO
- Mr. Vilhelm Robert Wessman
- Employees
- 1,460
- Headquarters
- Luxembourg, Luxembourg, Luxembourg
- Fiscal year end
- 12-31
- Website
- alvotech.com
Company profile
- Exchange
- US
- Symbol
- ALVO
- Market-cap rank
- #2709
- Listing date
- 2020-11-09
- Market cap
- 2.09B
- Float cap
- 823.27M
- Shares out
- 356.82M
- Float shares
- 140.73M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-10-08 09:12:43 · For reference only, not investment advice and not tailored to your situation.